skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

KHOURY, H. J ; KUKREJA, M ; GALE, R. P ; MARKS, D. I ; MCCARTHY, P. L ; WOOLFREY, A ; SZER, J ; GIRALT, S. A ; MAZIARZ, R. T ; CORTES, J ; HOROWITZ, M. M ; LEE, S. J ; GOLDMAN, J. M ; WANG, T ; HALTER, J ; ARORA, M ; GUPTA, V ; RIZZIERI, D. A ; GEORGE, B ; KEATING, A

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia, stem cells

JORDAN, C. T ; UPCHURCH, D ; LUGER, S. M ; PHILLIPS, G. L ; SZILVASSY, S. J ; GUZMAN, M. L ; HOWARD, D. S ; PETTIGREW, A. L ; MEYERROSE, T ; ROSSI, R ; GRIMES, B ; RIZZIERI, D. A

Leukemia, 2000-10, Vol.14 (10), p.1777-1784 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
3
High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma

Sivaraj, D ; Bacon, W ; Long, G D ; Rizzieri, D A ; Horwitz, M E ; Sullivan, K M ; Kang, Y ; Li, Z ; Chao, N J ; Gasparetto, C

Bone marrow transplantation (Basingstoke), 2018-01, Vol.53 (1), p.34-38 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Leukemic Stem Cells: A Review
Leukemic Stem Cells: A Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Leukemic Stem Cells: A Review

O'Brien, J. A. ; Rizzieri, D. A.

Cancer investigation, 2013-05, Vol.31 (4), p.215-220 [Periódico revisado por pares]

New York, NY: Informa Healthcare

Texto completo disponível

Citações Citado por
5
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

KANDA, J ; KAYNAR, L ; GASPARETTO, C ; CHUTE, J. P ; MORRIS, A ; WINKEL, S ; MCPHERSON, J ; KURTZBERG, J ; CHAO, N. J ; HORWITZ, M. E ; KANDA, Y ; PRASAD, V. K ; PARIKH, S. H ; LAN, L ; SHEN, T ; RIZZIERI, D. A ; LONG, G. D ; SULLIVAN, K. M

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.926-931 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration

HORWITZ, M. E ; CHUTE, J. P ; GASPARETTO, C ; LONG, G. D ; MCDONALD, C ; MORRIS, A ; RIZZIERI, D. A ; SULLIVAN, K. M ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2012-08, Vol.47 (8), p.1051-1055 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation

KANDA, J ; HORWITZ, M. E ; RIZZIERI, D. A ; LONG, G. D ; GASPARETTO, C ; SULLIVAN, K. M ; CHUTE, J. P ; MORRIS, A ; HENNIG, T ; LI, Z ; CHAO, N. J

Bone marrow transplantation (Basingstoke), 2012-05, Vol.47 (5), p.700-705 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors

CHEN, D.-F ; PRASAD, V. K ; LONG, G. D ; YANG, Y ; CHAO, N. J ; RIZZIERI, D. A ; BROADWATER, G ; REINSMOEN, N. L ; DEOLIVEIRA, A ; CLARK, A ; SULLIVAN, K. M ; CHUTE, J. P ; HORWITZ, M. E ; GASPARETTO, C

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.817-823 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection
Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection

BYRNE, B. J ; HORWITZ, M ; LONG, G. D ; GASPARETTO, C ; SULLIVAN, K. M ; CHUTE, J ; CHAO, N. J ; RIZZIERI, D. A

Bone marrow transplantation (Basingstoke), 2008-01, Vol.41 (1), p.39-43 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia

WEINBERG, J. B ; VOLKHEIMER, A. D ; RIZZIERI, D. A ; LEVESQUE, M. C ; DEKROON, R ; STRITTMATTER, W. J ; MIHOVILOVIC, M ; JIANG, N ; CHEN, Y ; BOND, K ; MOORE, J. O ; GOCKERMAN, J. P ; DIEHL, L. F ; DE CASTRO, C. M

Leukemia, 2008-12, Vol.22 (12), p.2184-2192 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (52)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.